Walleye Capital’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
Walleye Capital's AVXL Position: Q3 2026 in Review
Walleye Capital reduced its Anavex Life Sciences (AVXL) stake by 96% in Q3 2026, selling an estimated $805 and leaving 11 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #5903.
Walleye Capital first reported a position in AVXL in Q4 2025 and has held it in 4 quarters since. The position peaked at $21.4K in Q4 2025. 164 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- Walleye Capital held 11 shares of Anavex Life Sciences worth $22 as of Q3 2026.
- Walleye Capital sold 291 Anavex Life Sciences shares in Q3 2026, an estimated $805.
- Anavex Life Sciences made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5903 holding.
- Walleye Capital first reported a position in Anavex Life Sciences in Q4 2025 and has held it in 4 quarters since.
- Walleye Capital's Anavex Life Sciences position peaked at $21.4K in Q4 2025.
- 164 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.